Cargando…
New Approaches for Cryptococcosis Treatment
Cryptococcosis is an important opportunistic infection and a leading cause of meningitis in patients with HIV infection. The antifungal pharmacological treatment is limited to amphotericin B, fluconazole and 5- flucytosine. In addition to the limited pharmacological options, the high toxicity, incre...
Autores principales: | Spadari, Cristina de Castro, Wirth, Fernanda, Lopes, Luciana Biagini, Ishida, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232457/ https://www.ncbi.nlm.nih.gov/pubmed/32340403 http://dx.doi.org/10.3390/microorganisms8040613 |
Ejemplares similares
-
Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis
por: Spadari, Cristina de Castro, et al.
Publicado: (2019) -
Nanocarriers Provide Sustained Antifungal Activity for Amphotericin B and Miltefosine in the Topical Treatment of Murine Vaginal Candidiasis
por: de Bastiani, Fernanda Walt Mendes da Silva, et al.
Publicado: (2020) -
Potential Use of Alginate-Based Carriers As Antifungal Delivery System
por: Spadari, Cristina de Castro, et al.
Publicado: (2017) -
Searching for new antifungals for the treatment of cryptococcosis
por: de Sousa, Naira Sulany Oliveira, et al.
Publicado: (2023) -
Cryptococcosis
por: Haley, Lenore D.
Publicado: (1957)